Biocon Q3 FY23 revenue up 36% - indianpharmapost.com

Feb 17, 2023  · Biocon Ltd., an innovation-led global biopharmaceuticals company. has announced Q3 FY23 revenue at Rs.3,020 crore, up 36%. “Q3 FY23 has been an eventful …


Install CouponFollow Chrome Extension   CouponFollow Extension

36%
OFF

Biocon Q3 FY23 Revenue Up 36% - Indianpharmapost.com

2 weeks from now

Feb 17, 2023  · Biocon Ltd., an innovation-led global biopharmaceuticals company. has announced Q3 FY23 revenue at Rs.3,020 crore, up 36%. “Q3 FY23 has been an eventful …

indianpharmapost.com

36%
OFF

Biocon Limited Q3 FY23 Earnings Conference Call Transcript

2 weeks from now

At a consolidated group level, revenues for Q3 FY23 were up 36% on a year-on-year basis at ₹3,020 Crores. Revenues from our Biosimilars Business and Research Services Business …

biocon.com

36%
OFF

Biocon’s Q3 FY23 Revenue Stands At Rs 3,020 Crore, Up By 36%

2 weeks from now

Feb 15, 2023  · Biocon’s Q3 FY23 revenue stands at Rs 3,020 crore, up by 36%. The company's revenue from operations surged 35% YoY to Rs 2,941 crore for the third quarter under review, …

biovoicenews.com

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%, Biosimilars Up …

2 weeks from now

Feb 15, 2023  · Bengaluru - Biocon Ltd , an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the third quarter ended December 31, …

marketscreener.com

36%
OFF

Biocon Q3FY23 Earnings: Revenue Up 36%, PAT Falls 25% YoY

2 weeks from now

Feb 14, 2023  · Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY. With a market capitalization of ₹ 28,202.09 Cr, Biocon Ltd. is a large-cap company that engages in the …

livemint.com

36%
OFF

Biocon Limited (BIOCON) Q3 FY23 Earnings Concall Transcript

2 weeks from now

Feb 15, 2023  · At a consolidated Group level, revenues for Q3 FY23 were up 36% on a year-on year basis at INR3,020 crores. Revenues from our Biosimilars business and Research …

alphastreet.com

144%
OFF

Biocon Q3 Net Profit Falls 25 Per Cent; Revenue Up 36 Per Cent At Rs ...

2 weeks from now

Feb 15, 2023  · Biocon Q3 net profit falls 25 per cent; revenue up 36 per cent at Rs 3,020 crore. The company's net R&D investments for the quarter grew by 144% to Rs 337 crore, …

newindianexpress.com

59%
OFF

Biocon Reports Dip In PAT 25 Percent Yoy; Revenue Up 36 Percent …

2 weeks from now

Feb 14, 2023  · Tata Elxsi Q3 Results: Profit drops by 3.59% to Rs 199.01 crore, revenue up 2.73% YoY India’s biotech startup count jumped to 9,000 in 10 years: Jitendra Singh

financialexpress.com

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36%

2 weeks from now

Feb 14, 2023  · Biocon Q3FY23 revenue at Rs 3,020 crore, up 36% - Bengaluru, Feb 14 Global biopharmaceuticals company Biocon Ltd on Tuesday announced its net revenue from …

lokmattimes.com

36%
OFF

Biocon Ltd.(NSE: BIOCON) Ltd. : Q3 FY23 Results Out; Total Income …

2 weeks from now

Feb 14, 2023  · Biocon Ltd reported a 36% increase in consolidated revenue to Rs 3,020 crore in Q3FY23. The robust performance was driven by a 54% increase in revenue from its …

alphastreet.com

36%
OFF

Biocon Reports Net Loss Of Rs 42 Cr, Sales Up By 36% YoY In …

2 weeks from now

Feb 14, 2023  · The company's revenue for the third quarter stood at Rs 3,020 crores against Rs 2,223 crores in the same quarter last year. ... “Q3 FY23 has been an eventful quarter which …

businessworld.in

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36% - Magazinestime

2 weeks from now

Feb 15, 2023  · Bengaluru, Feb 14 (IANS) Global biopharmaceuticals company Biocon Ltd on Tuesday announced its net revenue from operations for the quarter, ending December 31, …

magazinestime.com

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36% – THIP Media

2 weeks from now

Bengaluru, Feb 14 (IANS) Global biopharmaceuticals company Biocon Ltd on Tuesday announced its net revenue from operations for the quarter, ending December 31, 2022. …

thip.media

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36%

2 weeks from now

Feb 15, 2023  · Bengaluru, Feb 14 (IANS) Global biopharmaceuticals company Biocon Ltd on Tuesday announced its net revenue from operations for the quarter, ending December 31, …

suryaa.com

50%
OFF

Biocon Q3FY24 Revenue At Rs 4,519 Cr, Up 50%; Biosimilars Up …

2 weeks from now

Feb 8, 2024  · Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 …

biocon.com

17%
OFF

Q3 Results Highlights: Bajaj Holdings' Revenue Up 17% ... - CNBCTV18

2 weeks from now

Jan 30, 2025  · Biocon’s financial performance for Q3 FY25 was in line with expectations.However, the year-on-year comparison is impacted by one-time gains recorded in Q3 FY24. In the …

cnbctv18.com

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%; Biosimilars Up …

2 weeks from now

Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%. Thu, 09-Mar-2023 ... BIOCON GROUP “Q3 FY23 has been an …

bioconbiologics.com

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36%

2 weeks from now

by IANS | . Bengaluru, Feb 14 (IANS) Global biopharmaceuticals company Biocon Ltd on Tuesday announced its net revenue from operations for the quarter, ending December 31, …

suryaa.com

5%
OFF

Biocon Buys Back An Investor Stake In Biologics Unit, Posts Rs 25 …

2 weeks from now

Jan 30, 2025  · Biocon's board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected to complete by February 1, …

indiatimes.com

FAQs about Biocon Q3 FY23 revenue up 36% - indianpharmapost.com Coupon?

How did Biocon perform in q3fy25?

Biocon reported 96% year-on-year (YoY) drop in net profit to Rs 25 crore in Q3FY25. The company reported net profit of Rs 660 crore during Q3FY24, aided by an exception item of Rs 566 crore. Revenue from operations rose 10% YoY to Rs 3821 crore in Q3FY25. EBITDA for the quarter rose 16% YoY to Rs 787 crore, representing an EBITDA margin of 20%. ...

What did Biocon & Biocon biologics do in Q3 FY23?

In Q3 FY23, Biocon and Biocon Biologics completed the global acquisition of their partnered Biosimilars business from Viatris on Nov 29, 2022. (Executive Chairperson, Kiran Mazumdar-Shaw made this announcement.) ...

How much revenue did Biocon biologics generate in fy24?

Good morning and thanks for the opportunity. You previously guided for US$ 1.8 bn revenue for Biocon Biologics in FY24 and the US$ 500 million EBITDA. So, are transaction with Serum? ...

Is Biocon a biopharmaceutical company?

Bengaluru, Karnataka, India: February 14, 2023: Biocon Ltd (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the third quarter ended December 31, 2022. ...

What were the Financial Highlights of Q3 FY23?

will now present the key financial highlights of the quarter. At a consolidated group level, revenues for Q3 FY23 were up 36% on a year-on-year basis at ₹3,020 Crores. ...

What is happening at Biocon Limited?

Biocon Limited's CEO & Managing Director, Siddharth Mittal, stated that their focus remains on geographical expansion, new product launches, strengthening their product pipeline, and executing on key capex projects. This was shared during the Biocon Limited Q3FY23 earnings. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension